Marco Weinberg

VP of R&D Gene Editing at Asklepios BioPharmaceuticals Inc - Durham, NC, US

Marco Weinberg's Colleagues at Asklepios BioPharmaceuticals Inc
Canwen Jiang

Chief Development Officer and Chief Medical Officer

Contact Canwen Jiang

Shiva Krupa

VP, Head of Portfolio & Program Management

Contact Shiva Krupa

Chris Mario

Director of Clinical Operations

Contact Chris Mario

Abbie Meyer

Senior Licensing and Alliance Manager

Contact Abbie Meyer

Ban Trinh

Director Accounting & Tax

Contact Ban Trinh

View All Marco Weinberg's Colleagues
Marco Weinberg's Contact Details
HQ
919-561-6210
Location
United States
Company
Asklepios BioPharmaceuticals Inc
Marco Weinberg's Company Details
Asklepios BioPharmaceuticals Inc logo, Asklepios BioPharmaceuticals Inc contact details

Asklepios BioPharmaceuticals Inc

Durham, NC, US • 250 - 499 Employees
BioTech/Drugs

Asklepios BioPharmaceutical, Inc. (AskBio) is a leading clinical-stage adeno-associated virus (AAV) gene therapy company dedicated to improving the lives of patients with rare disorders and other diseases.We've built a foundation of therapeutic programs, AAV manufacturing and a rich portfolio of patented technology. Our therapeutic focus includes neuromuscular, central nervous system, cardiovascular and metabolic diseases with clinical trials underway for Pompe disease, Parkinson's disease, and congestive heart failure. Our gene therapy platform includes Pro10™, an industry-leading proprietary cell line manufacturing process, and an extensive AAV capsid and promoter library.We became a wholly-owned, independently operated, subsidiary of Bayer AG in late 2020 as a cornerstone of its newly formed Cell & Gene Therapy (CGT) platform. Our global headquarters is in Research Triangle Park, NC. Additionally, we have significant operations in Philadelphia, PA, Columbus, OH, Scotland, France, and Spain.Vision - Pioneering science to create transformative molecular medicines.Mission - Lead innovative science and drive clinical outcomes to transform people's lives.Values:• Be a Pioneer. We are not afraid of the impossible and to innovate to make gene therapies accessible to those in need.• Cultivate Collaboration. Strive to be the best teammate, actively listen, openly communicate, and embrace diverse points of view.• Embrace Responsibility. We are humbled by the enormity of our mission. We hold a relentless commitment to advance science and clinical outcomes for our patients, families, and caregivers.• Raise the Bar. Continuously drive improvements and efficiencies. Seek and provide constructive feedback. Have a bias for learning and action.• Act with Uncompromising Integrity. Be honest, transparent, and committed to doing what's right in every situation. Make clear commitments and follow through.

AAV Adeno-Associated Virus Gene Therapy Rare Disease Pro10 AAV Manufacturing BioTech/Drugs Commercial Physical Research Biotechnology Biotech Pharmaceuticals
Details about Asklepios BioPharmaceuticals Inc
Frequently Asked Questions about Marco Weinberg
Marco Weinberg currently works for Asklepios BioPharmaceuticals Inc.
Marco Weinberg's role at Asklepios BioPharmaceuticals Inc is VP of R&D Gene Editing.
Marco Weinberg's email address is ***@askbio.com. To view Marco Weinberg's full email address, please signup to ConnectPlex.
Marco Weinberg works in the BioTech/Drugs industry.
Marco Weinberg's colleagues at Asklepios BioPharmaceuticals Inc are Canwen Jiang, Shiva Krupa, Chris Mario, Pamela Ghosh, Libbie Mansell, Abbie Meyer, Ban Trinh and others.
Marco Weinberg's phone number is 919-561-6210
See more information about Marco Weinberg